- Home
- NBTX vs MODV Comparison
NBTX vs MODV Comparison
Compare NBTX & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- MODV
- Stock Information
- Founded
- NBTX 2003
- MODV 1996
- Country
- NBTX France
- MODV United States
- Employees
- NBTX N/A
- MODV N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- NBTX Health Care
- MODV Consumer Discretionary
- Exchange
- NBTX Nasdaq
- MODV Nasdaq
- Market Cap
- NBTX 201.9M
- MODV 166.7M
- IPO Year
- NBTX 2020
- MODV N/A
- Fundamental
- Price
- NBTX $3.25
- MODV $5.94
- Analyst Decision
- NBTX Strong Buy
- MODV Buy
- Analyst Count
- NBTX 1
- MODV 5
- Target Price
- NBTX $12.00
- MODV $18.20
- AVG Volume (30 Days)
- NBTX 42.0K
- MODV 580.6K
- Earning Date
- NBTX 09-18-2024
- MODV 02-20-2025
- Dividend Yield
- NBTX N/A
- MODV N/A
- EPS Growth
- NBTX N/A
- MODV N/A
- EPS
- NBTX N/A
- MODV N/A
- Revenue
- NBTX $45,220,186.00
- MODV $2,787,619,000.00
- Revenue This Year
- NBTX N/A
- MODV $3.92
- Revenue Next Year
- NBTX N/A
- MODV $6.40
- P/E Ratio
- NBTX N/A
- MODV N/A
- Revenue Growth
- NBTX 526.17
- MODV 3.16
- 52 Week Low
- NBTX $2.76
- MODV $5.55
- 52 Week High
- NBTX $8.43
- MODV $52.33
- Technical
- Relative Strength Index (RSI)
- NBTX 56.43
- MODV 28.57
- Support Level
- NBTX $2.85
- MODV $5.55
- Resistance Level
- NBTX $3.07
- MODV $7.84
- Average True Range (ATR)
- NBTX 0.16
- MODV 1.42
- MACD
- NBTX 0.05
- MODV -0.32
- Stochastic Oscillator
- NBTX 73.67
- MODV 5.41
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.